Japan, June 10 -- AMGEN has got intellectual property rights for 'INTERLEUKIN-2 MUTEINS FOR EXPANSION OF T-REGULATORY CELLS.' Other related details are as follows:

Application Number: JP,2025-028631

Category (FI): A61P11/06,A61P43/00,111,C12N15/13,A61P19/02,C12N15/62@Z,C07K16/00,C07K19/00,C12N15/26,A61P17/06,A61P9/10,101,A61P15/06,A61P17/00,A61P1/04,A61K38/20,A61P29/00,101,C07K14/55,A61P9/14,A61P25/00,A61P37/02,A61P29/00,A61P37/06,A61P17/14,A61P3/10,A61P43/00,105,A61K47/65,A61K47/68

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 26, 2025

Publication Date: July 15, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.